This page contains brief information about zanubrutinib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Zanubrutinib is approved to treat:
- Mantle cell lymphoma in adults who have received at least one other type of treatment.
This use is approved under FDA’s Accelerated Approval Program. As a condition of approval, a confirmatory trial(s) must show that zanubrutinib provides a clinical benefit in these patients.
Zanubrutinib is also being studied in the treatment of other types of cancer.
More About Zanubrutinib
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Clinical Trials Accepting Patients
Find Clinical Trials for Zanubrutinib - Check for trials from NCI's list of cancer clinical trials now accepting patients.